echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Stroke: The relationship between plasma-containing sulfur amino acids and the risk of cerebrovascular disease

    Stroke: The relationship between plasma-containing sulfur amino acids and the risk of cerebrovascular disease

    • Last Update: 2021-01-01
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Vitamin B supplements can reduce the circulatory concentration of high cysteine and may reduce the risk of stroke.
    concentration of homocysteine was associated with the rate of stroke, but the association between other sulfur-containing compounds in the associated metabolic pathways and cerebrovascular disease has not been studied.
    researchers conducted a case-control study that included 480 patients with cerebrovascular disease and 480 controls matching the years of age, gender and baseline examination (1993-1997).
    researchers used baseline plasma samples to determine levels of sulfur-containing compounds, including methionine, homocysteine, cysteine, cysteine, glutathione and taurine, using liquid chromatography-series mass spectrometry.
    researchers assessed the relationship between the concentration of each compound and methionine to homocysteine (representing a carbon metabolic activity) and the risk of cerebrovascular disease, and adjusted for potential confluum factors.
    plasma methionine and methionine/homocysteine ratios were negatively associated with the risk of cerebrovascular disease, with a ratio of 0.83 (95% CI 0.72-0.96) and 0.82 (95% CI 0.71-0.95) for each additional SD.
    the same type of cysteine, the association between methionine and the risk of cerebrovascular disease remained significant.
    other assessed compounds were not related to cerebrovascular disease.
    results suggest that higher bioavailable use of methionine may play a role in preventing cerebrovascular disease and explain the previously known relationship between homocysteine and stroke.
    further research is needed to determine the cause and potential of circulating methionine as a target for the prevention of cerebrovascular diseases.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.